RetaXome™ A Breakthrough in Regenerative Skincare, Backed by Clinical Science

By Michael H. Gold, M.D., Medical Director, Gold Skin Care Center and Tennessee Clinical Research Center

As a dermatologist and clinical researcher, I’ve spent decades evaluating emerging skincare technologies—not just in theory, but in practice, through carefully conducted clinical studies. I’ve seen trends come and go, but every so often, something truly game-changing arrives.

RetaXome™ is one of those breakthroughs.

I had the privilege of serving as the lead investigator in the clinical trials for RetaXome, and I can confidently say this is a next-generation retinal solution unlike anything we’ve studied before. Hydrinity has created something truly unique: the first and only exosome-encapsulated retinal designed for nightly use from Day 1, with no acclimation period required. That’s a milestone in not only dermatologic skincare but regenerative medicine.

Why This Innovation Matters

Traditionally, retinal products—while powerful and require just one conversion to work—have been difficult for many patients to tolerate. Peeling, redness, and irritation often keep people from staying consistent long enough to see results. RetaXome addresses that head-on with a Triple Action Innovation that changes how retinal is delivered, absorbed, and experienced.

Triple Action Innovation:

• Proprietary Biomimetic Exosome Technology: Enhances delivery to the dermis, ensuring that the retinal reaches where it is needed most—without overwhelming the skin.
• Encapsulated Retinal: Delivers potent, fast-acting anti-aging results—10x more powerful and faster-acting than traditional retinol.
• Supercharged HA: Features dual-weight, 100% injectable-grade hyaluronic acid to deeply hydrate and support the skin barrier and boost retinal performance.

Clinically Proven Results

In our clinical trials, we saw remarkable outcomes in a diverse range of skin types, including sensitive and mature skin. Among the most significant findings:

• 44% increase in hydration at just 2 weeks
• 35% reduction in fine lines and wrinkles at 12 weeks
• 62% improvement in overall skin texture at 12 weeks
• 68% reduction in redness (erythema)—a major benefit for anyone prone to irritation—at 12 weeks

These results were not just measurable—they were visible and meaningful. Patients reported smoother, calmer, more radiant skin, often within the first few weeks of use.

As both a dermatologist and researcher, I’ve always looked for products that combine strong science with a high standard of care. RetaXome is that product. It delivers the kind of results we’ve hoped for in a retinal—without the irritation that used to come with the territory.

If you're someone who has avoided retinoids due to sensitivity, or if you're simply ready to experience faster, deeper results, RetaXome represents the next evolution in skin renewal. I’ve seen the transformation firsthand, and I now confidently recommend it to my patients as part of a consistent nightly routine.

To experience the power of RetaXome for yourself, talk to your dermatologist or visit a Hydrinity provider near you. Your best skin isn’t a someday goal—it starts tonight.